LINC00261 and cholangiocarcinoma: LINC00261 is abnormally expressed in a variety of tumors such as gastric, colorectal, lung, breast, laryngeal, prostate, endometrial, esophageal, prostate, cholangiocarcinoma, and hepatocellular carcinoma [94].